BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Assets | ₹94 Cr | ₹87 Cr | ₹51 Cr | ₹50 Cr | ₹36 Cr |
What is the latest Total Current Assets ratio of BAFNA PHARMACEUTICALS ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹94 Cr |
Mar2023 | ₹87 Cr |
Mar2022 | ₹51 Cr |
Mar2021 | ₹50 Cr |
Mar2020 | ₹36 Cr |
How is Total Current Assets of BAFNA PHARMACEUTICALS Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹94 Cr | 8.20 | |
Mar2023 | ₹87 Cr | 71.60 | |
Mar2022 | ₹51 Cr | 2.44 | |
Mar2021 | ₹50 Cr | 38.43 | |
Mar2020 | ₹36 Cr | - |
Compare Total Current Assets of peers of BAFNA PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAFNA PHARMACEUTICALS | ₹192.0 Cr | -5.8% | 1.3% | -3.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,382.0 Cr | -3.7% | -2.5% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,224.0 Cr | 2.3% | 2.1% | 46.9% | Stock Analytics | |
CIPLA | ₹116,943.0 Cr | -3.2% | 0% | 8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,588.0 Cr | -2.4% | 7.3% | 15.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,704.0 Cr | 2% | 2.3% | 37.9% | Stock Analytics |
BAFNA PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAFNA PHARMACEUTICALS | -5.8% |
1.3% |
-3.1% |
SENSEX | -2.2% |
-5.9% |
7.2% |
You may also like the below Video Courses